The team of María Domínguez, researcher for the Neuroscience Institute, joint venture of the Miguel Hernández University in Elche and the Spanish National Research Council, has managed to prove for the first time that an important factor in the development of acute pediatric lymphoblastic leukemia is inflammation.
Women in rural India are waiting long before seeking medical care for breast cancer. Most of the Indian women do not know the possibility of inspecting their own body and many of them have not even heard of breast cancer. This is shown in a new dissertation at Umeå University, Sweden.
The anatomic and physiologic structure of the eyes constitutes by itself an important barrier when administering medicine. The amount of medicine that passes through the cornea by applying creams or drops is very limited and it is necessary to develop alternative, more effective ways of administering them ocularly.
Sounds, photographs, light. Three elements are combined to create virtual nature spaces in Metla House, Joensuu. The famous wooden office building has housed innovative solutions since it was built. This time, the aim is to test virtual nature in practice and help budding enterprises find each other.
Americans fill about 4.5 billion prescriptions each year, at a cost of more than $323 billion. But what are we actually buying? In 11 states, the top prescriptions are opioid pain pills that are mixtures of acetaminophen and hydrocodone (brand names Vicodin and Norco), according to new data from GoodRx, an online prescription cost service.
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, today announces that its next-generation sequencing-based MammaPrint BluePrint Breast Cancer Recurrence and Molecular Subtyping Kit is now CE marked, enabling the Company to commercialize the device in Europe.
Neem Biotech, a Wales-based R&D biotech working in the field of novel antimicrobial drug development, announced today that it will be presenting results of its ongoing development work into the impact of NX-AS-401, its lead candidate,on biofilms in chronic cystic fibrosis lung infections at the 15th European Cystic Fibrosis Basic Science Conference taking place from […]